Sankar Kamya, Stein Brady L, Rampal Raajit K
Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Medicine/Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Cancer Treat Res. 2019;179:159-178. doi: 10.1007/978-3-030-20315-3_11.
The myeloproliferative neoplasms (MPNs) are clonal stem cell-derived diseases. This chapter focuses on the subcategory of Philadelphia (Ph) chromosome-negative classical MPNs, polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF). These MPNs are associated with both microvascular and macrovascular thrombosis, which may occur in the venous and arterial circulation. Erythrocytosis, leukocytosis, and increased JAK2V617F allele burden are known to be risk factors. In this chapter, we review the thrombotic and hemostatic manifestations of the Philadelphia (Ph) chromosome-negative classical MPNs, including the clinical manifestations, the pathophysiology, as well as management.
骨髓增殖性肿瘤(MPN)是克隆性干细胞来源的疾病。本章重点关注费城(Ph)染色体阴性的经典MPN亚类,即真性红细胞增多症(PV)、原发性血小板增多症(ET)、原发性骨髓纤维化(PMF)。这些MPN与微血管和大血管血栓形成相关,可发生于静脉和动脉循环。已知红细胞增多、白细胞增多和JAK2V617F等位基因负担增加是危险因素。在本章中,我们回顾费城(Ph)染色体阴性的经典MPN的血栓形成和止血表现,包括临床表现、病理生理学以及管理。